JR's 2026 Predictions – Biotech's Best Kept Secret: My #1 Pick of 2026 Yesterday, I revealed how biotech stocks are being thrust back in the spotlight as a whole wave of innovations in AI spark major overhauls in everything from drug discovery to diagnostic imaging. I showed you three of the best stocks plays I’m watching right now. And I mentioned one major name that I didn’t want to fully break down – until today. Regenxbio is a gene-therapy name with a clear catalyst, a rare-disease focus, and a setup where structure and risk management matter more than opinions. It’s higher risk than the names I talked about yesterday. But it also has meaningfully higher upside. One stock. One catalyst. And one clear outcome I’m watching in 2026. Today, I’m breaking down a new trade setup in Regenxbio that you won’t want to miss. This stock is the perfect opportunity for early investors to make a land grab in biotech. It’s one of my highest-conviction trade ideas of 2026. Just click here to access my YouTube channel and watch my breakdown of Regenxbio. And if you want to learn more about how I identify, filter, and manage trades like these step by step…
Make sure you check out The Masters in Trading Challenge. The Challenge is where we take everything you’ve learned in my daily LIVEs — fixed risk, thesis-driven exits, laddered entries, defined-duration trades, and emotional discipline — and put it into practice in a structured, step-by-step environment. For two weeks, we walk through the foundations of real options trading the way I learned them on the trading floor. You’ll learn exactly how I think, exactly how I build trades, and exactly how I manage both the winners and the losers. Just click here to check out what the Masters in Trading Options Challenge has in store for you. Remember, the creative trader wins | 
0 Response to "JR’s 2026 Predictions – Biotech’s Best Kept Secret: My #1 Pick of 2026"
Post a Comment